ArticleBMC infectious diseases2025
Interrupted-time-series analysis of the impact of COVID-19 pandemic on blood culture utilization in Shanghai.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundLimited information is available regarding the changes in blood culture utilization following the COVID-19 pandemic. Blood culture utilization rate is a critical indicator of diagnostic efficiency for infectious diseases. This study aims to describe the impact of the COVID-19 pandemic on blood culture utilization rate in Shanghai.
methodsWe conducted an interrupted time-series analysis based on electronic health records from the Shanghai Changzheng hospital from January 2014 to October 2023. The outcome measure was the rate of blood culture utilization among inpatients with a temperature of ≥ 39.4 °C. The impact of the COVID-19 pandemic on blood culture utilization was quantified by fitting linear segmented regression models and modelling the relative cumulative effect by the end of the study. The pandemic period was defined from February 2020, following the implementation of strict containment measures in Shanghai.
resultsA total of 23,761 inpatients with a temperature of ≥ 39.4 °C were included in the analysis. From 2014 to 2023, the utilization rate of hospital blood cultures increased initially and then declined, with a significant change point following the onset of the COVID-19 pandemic (Cochran-Armitage trend test, P < 0.001). The COVID-19 pandemic was associated with a significant change in the slope of the blood culture utilization rate (pre-COVID-19 vs. during-COVID-19: 0.31% per month vs. -0.30% per month, P < 0.001), resulting in a relative cumulative effect of -12.55% at the end of the study (95% confidence interval, -19.08 to -6.03). This corresponds to 407 inpatients who did not have blood cultures taken during-pandemic, which represents a significant deviation from pre-pandemic trends.
conclusionsThe upward trend in blood culture utilization rate among inpatients stalled during the COVID-19 pandemic and did not return to pre-pandemic levels following the pandemic. These findings suggest that the pandemic had a lasting impact on diagnostic practices. More targeted intervention measures are needed to promote appropriate utilization of blood cultures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.